GC-C Agonists: Specific Probes for the Detection of Colorectal Tumors
GC-C 激动剂:用于检测结直肠肿瘤的特异性探针
基本信息
- 批准号:8228577
- 负责人:
- 金额:$ 17.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenocarcinomaAffinityAgonistAmino AcidsAnimalsApplications GrantsAreaBindingBiological MarkersBiomedical ResearchCell LineClinicalClinical TrialsColitisCollaborationsColonColon AdenocarcinomaColon CarcinomaColonic NeoplasmsColonic PolypsColorectalColorectal AdenomaColorectal CancerColorectal NeoplasmsColorectal PolypCyclic GMPDataDetectionDevelopmentDigestionDoseEarly DiagnosisEctopic ExpressionEnsureEpithelial CellsEvaluationFluorescent ProbesFluorochromeFutureGastrointestinal tract structureGlycoproteinsGoalsGrowthGuanylate CyclaseHistologicHomeostasisHumanImageIn VitroIncubatedInflammationIntestinal NeoplasmsIntestinesIonsLarge Intestine CarcinomaLeadLesionLigandsLiquid substanceMalignant Epithelial CellMalignant NeoplasmsMeasurableMethodsMicroscopicMorbidity - disease rateMorphologyMouse StrainsMucous MembraneMusNIH Program AnnouncementsNatriuretic FactorsNeoplasm MetastasisNeoplastic ProcessesNormal tissue morphologyOral AdministrationPathologyPeptide HydrolasesPeptidesPharmacodynamicsPhysiologicalPolypsProductionProteolysisPublic HealthReportingResearchResearch Project GrantsResistanceScheduleSensitivity and SpecificitySignal TransductionSimulateSpecificityStomachTestingTissuesTranslationsTraveler&aposs diarrheaTumor TissueUnited States National Institutes of HealthUpper digestive tract structureValidationWateranalogbasebrush border membranecancer typedesigndisulfide bondenterotoxin STgastrointestinalguanylinimaging modalityimaging probein vivoinnovationmRNA Expressionmortalitymouse modelneoplastic cellnovel strategiesoverexpressionpeptide hormonephase 1 studypre-clinicalpreclinical studyprogramsreceptorresponseselective expressiontime intervaltumoruroguanylin
项目摘要
DESCRIPTION (provided by applicant): Uroguanylin (UG) and guanylin (GN) are endogenous agonists of the guanylate cyclase C (GC-C) receptor that were discovered as natriuretic hormones based on their structural similarity to bacterial enterotoxin (ST), the secreted peptide that is responsible for traveler's diarrhea. Binding of these peptide hormones to the GC-C receptor stimulates intracellular production of cyclic guanosine monophosphate (cGMP), which in turn regulates ion and water homeostasis within the gastrointestinal mucosa. This group was the first to report that the expression of mRNAs encoding UG and GN are markedly reduced in cultured human colon carcinoma cells as well as human colon polyps and adenocarcinomas. In contrast, GC-C is overexpressed in human colon polyps and tumor tissues, perhaps to compensate for the reduced supply of UG and GN. The hypothesis of the proposed study is that near-infrared (NIR) fluorochrome-tagged SP-333, a stable analog of UG, can be used as a noninvasive probe for the reliable detection of spontaneous colorectal polyps in multiple intestinal neoplasia mice, in particular lesions that lack an elevated growth component. Preliminary data indicate that SP-333, a proteolytically resistant analog of UG, 1) possesses a high binding affinity for GC-C receptors; 2) is stable in simulated human gastric and intestinal fluids at 37oC; 3) can be tagged with an NIR fluorochrome; and 4) localizes preferentially to colorectal polyps, as compared to adjacent normal colonic mucosa, when incubated with mouse tissue ex vivo. These data support the further characterization and validation of NIR fluorochrome-tagged SP-333 as a specific probe for the detection of colorectal tumors in Dr. Clapper's strain of mice (Apc?FCCC) that uniquely develops multiple colorectal polyps. Specific Aim 1 will focus on determining the stability of NIR fluorochrome-tagged SP-333 in simulated intestinal and gastric fluids as well as the specificity of its binding to human carcinoma cells in vitro and excised colon tissue (normal and tumor). Once the optimal dose and schedule for probe administration have been established, its sensitivity and specificity to detect spontaneous colorectal polyps following oral administration to mice will be determined (Specific Aim 2). The proposed research will be accomplished jointly in collaboration with Dr. Clapper's group, who has recently established several imaging modalities for the detection of colorectal polyps in Apc?FCCC mice. Successful completion of the proposed research will have demonstrated the proof-of-concept that the GC-C agonist SP-333 can be used as a probe to reliably detect primary colon tumors, thus supporting its further development for translation to a clinical setting. Future evaluation of the utility of the probe to detect colorectal metastases may also be warranted.
PUBLIC HEALTH RELEVANCE: Relevance to Public Health Use of SP-333 as a fluorescent probe to detect colon tumor cells could lead to early diagnosis of colon polyps and tumors, potentially resulting reduced morbidity and mortality associated with colon cancer.
描述(由申请人提供):尿鸟苷素 (UG) 和鸟苷素 (GN) 是鸟苷酸环化酶 C (GC-C) 受体的内源性激动剂,由于其与细菌肠毒素 (ST) 的结构相似性而被发现为利尿钠激素,而细菌肠毒素 (ST) 是导致旅行者腹泻的分泌肽。这些肽激素与 GC-C 受体的结合刺激细胞内产生环磷酸鸟苷 (cGMP),从而调节胃肠粘膜内的离子和水稳态。该小组首次报道了在培养的人结肠癌细胞以及人结肠息肉和腺癌中编码UG和GN的mRNA表达显着降低。相比之下,GC-C 在人类结肠息肉和肿瘤组织中过度表达,这可能是为了补偿 UG 和 GN 供应的减少。该研究的假设是,近红外(NIR)荧光染料标记的 SP-333(UG 的稳定类似物)可用作非侵入性探针,用于可靠检测多发性肠道肿瘤小鼠中的自发性结直肠息肉,特别是缺乏升高的生长成分的病变。初步数据表明,SP-333是UG的一种蛋白水解抗性类似物,1)对GC-C受体具有高结合亲和力; 2)在37℃模拟人体胃液和肠液中稳定; 3) 可以用近红外荧光染料标记; 4) 当与小鼠组织离体培养时,与邻近的正常结肠粘膜相比,优先定位于结直肠息肉。这些数据支持进一步表征和验证近红外荧光染料标记的 SP-333 作为一种特异性探针,用于检测 Dr. Clapper 小鼠品系 (Apc?FCCC) 中的结直肠肿瘤,该小鼠品系独特地产生多发性结直肠息肉。具体目标 1 将重点确定 NIR 荧光染料标记的 SP-333 在模拟肠液和胃液中的稳定性,以及其与体外人类癌细胞和切除的结肠组织(正常和肿瘤)结合的特异性。一旦确定了探针给药的最佳剂量和时间表,将确定其在小鼠口服给药后检测自发性结直肠息肉的敏感性和特异性(具体目标 2)。拟议的研究将与 Clapper 博士的团队合作共同完成,Clapper 博士的团队最近建立了几种用于检测 Apc?FCCC 小鼠结直肠息肉的成像模式。拟议研究的成功完成将证明 GC-C 激动剂 SP-333 可用作可靠检测原发性结肠肿瘤的探针,从而支持其进一步开发并转化为临床环境。未来对探针检测结直肠转移的效用进行评估也可能是有必要的。
公共卫生相关性:与公共卫生的相关性 使用 SP-333 作为荧光探针来检测结肠肿瘤细胞可以实现结肠息肉和肿瘤的早期诊断,从而可能降低与结肠癌相关的发病率和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGIE L. CLAPPER其他文献
MARGIE L. CLAPPER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGIE L. CLAPPER', 18)}}的其他基金
Colorectal Cancer (CRC) Prevention by Urolithin A in Rodent CRC models
在啮齿动物 CRC 模型中通过尿石素 A 预防结直肠癌 (CRC)
- 批准号:
10885222 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center
福克斯蔡斯癌症中心的癌症预防-拦截靶向药物发现计划
- 批准号:
10505611 - 财政年份:2022
- 资助金额:
$ 17.66万 - 项目类别:
Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis
叶酸补充剂和结肠炎相关的结肠癌发生
- 批准号:
10446361 - 财政年份:2022
- 资助金额:
$ 17.66万 - 项目类别:
Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis
叶酸补充剂和结肠炎相关的结肠癌发生
- 批准号:
10620720 - 财政年份:2022
- 资助金额:
$ 17.66万 - 项目类别:
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites
从不吸烟者的肺癌:雌激素及其代谢物的作用
- 批准号:
10310863 - 财政年份:2018
- 资助金额:
$ 17.66万 - 项目类别:
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites
从不吸烟者的肺癌:雌激素及其代谢物的作用
- 批准号:
10338105 - 财政年份:2018
- 资助金额:
$ 17.66万 - 项目类别:
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites
从不吸烟者的肺癌:雌激素及其代谢物的作用
- 批准号:
10092971 - 财政年份:2018
- 资助金额:
$ 17.66万 - 项目类别:
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites
从不吸烟者的肺癌:雌激素及其代谢物的作用
- 批准号:
10524086 - 财政年份:2018
- 资助金额:
$ 17.66万 - 项目类别:
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias
扁平和息肉样结肠炎相关不典型增生的靶向化学预防
- 批准号:
9130172 - 财政年份:2015
- 资助金额:
$ 17.66万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:














{{item.name}}会员




